Industry News
Plenty of cash for Peplin
Peplin reports healthy cash balance [ + ]
Novogen subsidiary files IND
Marshall Edwards files IND for chemo-sensitising agent [ + ]
Prana looks at Huntington’s
Prana to investigate lead candidate in Huntington’s disease [ + ]
Biotech in brief
BioDiem, Anadis [ + ]
Toothy heroes in a half-shell
Earliest known turtle fossils shed light on shell development [ + ]
Protein arrests cervical cancer growth
BMP7 inhibits telomerase activity and cervical cancer cell growth [ + ]
Arana's pilot for arthritis
Arana to run dosage trial for rheumatoid arthritis application [ + ]
Avexa completes “jewel” recruitment
Avexa concludes recruitment for Phase III, reducing cash burn [ + ]
Polartechnics forecasts profit
Polartechnics claims future profits in cervical cancer test [ + ]
Metabolomics – the final frontier
Metabolomics is taking its place alongside genomics, transcriptomics and proteomics at the forefront of Australian research. [ + ]
Uncovering the parasite metabolome
How metabolomics took on scientist from studying Antarctic microbiology to tropical parasitology. [ + ]
New centre to fight infectious diseases
The China–Australia Centre for Phenomics Research at The Australian National University has been officially opened. The centre will focus on alterations in the genome code.
[ + ]Drastic cost-cutting at Benitec
Benitec retrenches staff to reduce cash burn [ + ]
AH&MRC profile: Mike McGuckin
Who would have thought that a few incontinent mice dubbed Winnie and Eeyore could reveal a whole new way of thinking about and possibly treating inflammatory bowel disease in humans? [ + ]
